Representative before the EPO

Company dna symphogen a slash s
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

Henrik Bendiksen has worked on the following 13 EPO patent applications which have been published in the last five years:

EP11733805

METHOD FOR HARVESTING EXPRESSION PRODUCTS

IPC classification:
C12N 7/02, C12N 15/10
Applicant:
Bavarian Nordic A/S
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP12794878

POXVIRUS VECTOR FOR THE EXPRESSION OF BACTERIAL ANTIGENS LINKED TO TETANUS TOXIN FRAGMENT C

IPC classification:
A61K 39/02, C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP13708667

AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13

IPC classification:
A61K 31/7088, A61P 31/04, A61P 37/02, C12N 15/117
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13730812

POXVIRAL VECTORS FOR LOW ANTIBODY RESPONSE AFTER A FIRST PRIMING IMMUNIZATION

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION IN PROGRESS
EP13717721

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

IPC classification:
A61K 39/155, C12Q 1/68
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP13717720

METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES

IPC classification:
A61K 39/00, A61K 39/12
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13783852

PR13.5 PROMOTER FOR ROBUST T-CELL AND ANTIBODY RESPONSES

IPC classification:
A61K 39/00, C12N 15/863
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13154196

Methods for treating cancer with MVA

IPC classification:
A61K 39/00, A61K 39/285, A61P 35/00, C07K 14/47
Applicant:
Bavarian Nordic A/S
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP11723884

NOVEL INTERFERON-ALPHA-PRODUCING BONE MARROW DENDRITIC CELLS

IPC classification:
A61K 39/00, C12N 5/0784
Applicant:
Bavarian Nordic A/S
Agent:
Multiple attorneys, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP14803277

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST AND/OR AGONIST OF AN IMMUNE CHECKPOINT INHIBITOR

IPC classification:
A61K 39/00
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP14806215

COMPOSITIONS AND METHODS VECTORS FOR INDUCING AN ENHANCED IMMUNE RESPONSE USING POXVIRUS VECTORS

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP15724454

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3

IPC classification:
A61K 39/00, A61K 39/395
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP15766889

METHODS AND COMPOSITIONS FOR INTRA-NASAL IMMUNIZATION WITH RECOMBINANT MVA ENCODING FLAGELLIN

IPC classification:
A61K 39/00, A61K 39/39, C07K 14/255
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
Request for examination was made

Please Sign in to use this feature